Sarcoma  >>  Vitrakvi (larotrectinib)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Vitrakvi (larotrectinib) / Bayer
NCT04945330: NTRK Gene Fusion - Positive Advanced or Recurrent Solid Tumors, a Rare Cancer Caused by Specific Changes in the Genes

Recruiting
N/A
100
Japan
Larotrectinib (Vitrakvi, BAY2757556)
Bayer
Advanced or Recurrent Solid Tumor Harboring an NTRK Gene Fusion
06/29
12/29

Download Options